Literature DB >> 28919159

Host control of human papillomavirus infection and disease.

John Doorbar1.   

Abstract

Most human papillomaviruses cause inapparent infections, subtly affecting epithelial homeostasis, to ensure genome persistence in the epithelial basal layer. As with conspicuous papillomas, these self-limiting lesions shed viral particles to ensure population level maintenance and depend on a balance between viral gene expression, immune cell stimulation and immune surveillance for persistence. The complex immune evasion strategies, characteristic of high-risk HPV types, also allow the deregulated viral gene expression that underlies neoplasia. Neoplasia occurs at particular epithelial sites where vulnerable cells such as the reserve or cuboidal cells of the cervical transformation zone are found. Beta papillomavirus infection can also predispose an individual with immune deficiencies to the development of cancers. The host control of HPV infections thus involves local interactions between keratinocytes and the adaptive immune response. Effective immune detection and surveillance limits overt disease, leading to HPV persistence as productive microlesions or in a true latent state.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  CIN; Epithelial homeostasis; HPV; Infection; Papillomavirus; Wart

Mesh:

Substances:

Year:  2017        PMID: 28919159     DOI: 10.1016/j.bpobgyn.2017.08.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  27 in total

1.  Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation.

Authors:  Brittany L Woodby; William K Songock; Matthew L Scott; Gaurav Raikhy; Jason M Bodily
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 2.  The long and winding road: human papillomavirus entry and subcellular trafficking.

Authors:  Michelle A Ozbun; Samuel K Campos
Journal:  Curr Opin Virol       Date:  2021-08-17       Impact factor: 7.121

3.  AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections.

Authors:  Judith A Smith; Anjali A Gaikwad; Lata Mathew; Barbara Rech; Jonathan P Faro; Joseph A Lucci; Yu Bai; Randall J Olsen; Teresa T Byrd
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 4.  Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.

Authors:  Alexandru Barboi; Christopher H Gibbons; Felicia Axelrod; Eduardo E Benarroch; Italo Biaggioni; Mark W Chapleau; Gisela Chelimsky; Thomas Chelimsky; William P Cheshire; Victoria E Claydon; Roy Freeman; David S Goldstein; Michael J Joyner; Horacio Kaufmann; Phillip A Low; Lucy Norcliffe-Kaufmann; David Robertson; Cyndya A Shibao; Wolfgang Singer; Howard Snapper; Steven Vernino; Satish R Raj
Journal:  Clin Auton Res       Date:  2019-09-02       Impact factor: 4.435

5.  Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.

Authors:  Matthew L Scott; Brittany L Woodby; Joseph Ulicny; Gaurav Raikhy; A Wayne Orr; William K Songock; Jason M Bodily
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

Review 6.  Epidemiology and biology of cutaneous human papillomavirus.

Authors:  Emily M Nunes; Valéria Talpe-Nunes; Laura Sichero
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

7.  Switches of SOX17 and SOX2 expression in the development of squamous metaplasia and squamous intraepithelial lesions of the uterine cervix.

Authors:  Jobran M Moshi; Klaas J Hoogduin; Monique Ummelen; Mieke E R Henfling; Manon van Engeland; Kim A D Wouters; Hans Stoop; Imke Demers; Leendert H J Looijenga; Frans C S Ramaekers; Anton N H Hopman
Journal:  Cancer Med       Date:  2020-07-09       Impact factor: 4.452

8.  Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas.

Authors:  Larisse Silva Dalla Libera; Thalita de Siqueira; Igor Lopes Santos; Jéssica Enocencio Porto Ramos; Amanda Xavier Milhomen; Rita de Cassia Gonçalves de Alencar; Silvia Helena Rabelo Santos; Megmar Aparecida Dos Santos Carneiro; Rosane Ribeiro Figueiredo Alves; Vera Aparecida Saddi
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

9.  A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer.

Authors:  Nicole G Campos; Maria Demarco; Laia Bruni; Kanan T Desai; Julia C Gage; Sally N Adebamowo; Silvia de Sanjose; Jane J Kim; Mark Schiffman
Journal:  Prev Med       Date:  2021-03-04       Impact factor: 4.018

Review 10.  Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence.

Authors:  Eva H Clark; Robert H Gilman; Elizabeth Y Chiao; Patti E Gravitt
Journal:  Am J Trop Med Hyg       Date:  2021-07-19       Impact factor: 3.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.